
France · Medical devices startup
Companion Spine is a French-American medical technology company founded in 2020, focused on the interventional treatment of back pain.
Funding reportedLast round: Series A
Follow Companion Spine and see its new rounds in your feed.Start following
Companion Spine is a French-American medical technology company founded in 2020, focused on the interventional treatment of back pain.
With dual headquarters in New York and Bordeaux/Mérignac, the company aims to provide earlier, safer, and better solutions for relieving back pain while preserving natural anatomy and joint function. It has raised over $68.5 million in funding and employs approximately 11-50 people. The company offers a range of diagnostic tools, pain management solutions, and minimally invasive surgical implants. Its flagship products include the DIAM Spinal Implant for degenerative disc disease, the APERIUS Intervertebral Implant for lumbar stenosis, and the SMARTTM Technology Platform, which provides safe and reversible treatment options. Companion Spine serves patients suffering from back and leg pain, as well as medical professionals and outpatient centers looking for effective treatment alternatives. Through strategic acquisitions, it has enhanced its portfolio and solidified its position in the spine care ecosystem.
Funding, as reported
From Companion Spine's own website: 6 on the team.
What they build
Known for
health carespinal motion preservationspine carepain managementspinal stenosis treatmentmedical equipment manufacturingminimally invasive treatmentsdiagnostic technologyhospital & health caredegenerative disc disease solutionsoutpatient proceduresspinal disease detectionsurgical instrumentshealthbiological factors in painservices
Built with from their website
Yoast SEOGoogle MapsGoogle Tag ManagerWordPress.orgFont AwesomeElementorYouTubeViewport MetaYoastSite Kit
Google AnalyticsAnimate.cssWP EngineGoogle Analytics 4Microsoft OfficeWordpressMicrosoft Exchange OnlineGoogle Cloud Hosting
Add your raise, your deck and your story, and put Companion Spine in front of investors. Or tell us what we have wrong.